3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Active not recruiting
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Non-Hodgkin
8
Lymphoma
8
Leukemia, Myeloid, Acute
8
Multiple Myeloma
6
Myelodysplastic Syndromes
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myeloid, Chronic-Phase
5
Neuroblastoma
4
Hodgkin Disease
4
Graft vs Host Disease
4
Congenital Abnormalities
4
Recurrence
3
Neoplasms, Plasma Cell
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Follicular
3
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Burkitt Lymphoma
3
Sarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Accelerated Phase
2
Interventions
Immunotherapy, Adoptive
2
flumatinib
1
fludarabine
1
Thiotepa
1
Sensitivity and Specificity
1
Imatinib Mesylate
1
Idarubicin
1
Diagnosis
1
Deferasirox
1
Decitabine
1
Daunorubicin
1
Cytarabine
1
Cladribine
1
Busulfan
1
Blood Specimen Collection
1
Azacitidine
1
Anthracyclines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Leukemia, Myeloid
×
Busulfan
×
Clear all
NCT02333838
2018-08-13
TBF-Cord
Assistance Publique - Hôpitaux de Paris
Phase 2
Unknown
31 enrolled